Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Lamin A/C (LMNA) (C-Term) Peptid

LMNA Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN5511334
  • Target Alle Lamin A/C (LMNA) Produkte
    Lamin A/C (LMNA)
    Protein Region
    C-Term
    Spezies
    Human
    Quelle
    • 6
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB)
    Sequenz
    RTSGRVAVEE VDEEGKFVRL RNKSNEDQSM GNWQIKRQNG DDPLLTYRFP
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti-LMNA Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    Lamin A/C (LMNA)
    Synonyme
    CDCD1 Peptide, CDDC Peptide, CMD1A Peptide, CMT2B1 Peptide, EMD2 Peptide, FPL Peptide, FPLD Peptide, FPLD2 Peptide, HGPS Peptide, IDC Peptide, LDP1 Peptide, LFP Peptide, LGMD1B Peptide, LMN1 Peptide, LMNC Peptide, LMNL1 Peptide, PRO1 Peptide, Dhe Peptide, 2459 Peptide, 74/76 Peptide, CG6944 Peptide, D5 Peptide, DM[[O]] Peptide, Dm Peptide, Dm(0) Peptide, Dm0 Peptide, Dm1 Peptide, Dm2 Peptide, DmLamin Peptide, DmO Peptide, Dm[[0]] Peptide, Dm[[1]] Peptide, Dm[[2]] Peptide, Dm[[mit]] Peptide, Dm[[o]] Peptide, Dmel\\CG6944 Peptide, Dmo Peptide, LAM Peptide, Lam Dm[[0]] Peptide, Lam(Dm0) Peptide, LamDm[[0]] Peptide, LamDm[[o]] Peptide, Lam[[Dm0]] Peptide, Lamin Dm[[0]] Peptide, jf27 Peptide, l(2)04643 Peptide, l(2)25Ec Peptide, l(2)gdh-7 Peptide, l(2)gdh7 Peptide, l(2)jf27 Peptide, lam Peptide, lamDm0 Peptide, lamDm[[0]] Peptide, lamin Peptide, lamin Dm0 Peptide, lamin Dm[[0]] Peptide, misg Peptide, nlam Peptide, cb948 Peptide, fk66d12 Peptide, wu:fk66d12 Peptide, lmna-A Peptide, fpl Peptide, idc Peptide, lfp Peptide, cddc Peptide, emd2 Peptide, fpld Peptide, hgps Peptide, ldp1 Peptide, lmn1 Peptide, lmnc Peptide, pro1 Peptide, cdcd1 Peptide, cmd1a Peptide, cmt2b1 Peptide, lgmd1b Peptide, Lamin-A Peptide, lamin-L(III)-like Peptide, lamin A/C Peptide, lamin A Peptide, Lamin Peptide, lamin A/C L homeolog Peptide, lamin-L(III)-like Peptide, LMNA Peptide, Lmna Peptide, Lam Peptide, lmna Peptide, lmna.L Peptide, LMINA Peptide
    Hintergrund
    The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome.

    Alias Symbols: LMNA,LMN1,

    Protein Size: 664
    Gen-ID
    4000
    UniProt
    P02545
Sie sind hier:
Kundenservice